Showing 401-410 of 450 results for "".
- Aura Biosciences Doses First Patient in Phase 2 Study Evaluating Suprachoroidal Administration of AU-011 in Patients with Choroidal Melanomahttps://modernod.com/news/aura-biosciences-doses-first-patient-in-phase-2-study-evaluating-suprachoroidal-administration-of-au-011-in-patients-with-choroidal-melanoma/2478272/Aura Biosciences announced the dosing of the first patient in a phase 2 study evaluating the safety and efficacy of suprachoroidal (SC) administration of AU-011, the company’s lead product candidate, as a potential first-line treatment for patients with primary choroidal melanoma. “I am ho
- Clearside Biomedical’s Partner Doses First Patient in its Phase 2 Study in Patients with Choroidal Melanoma Using SCS Microinjectorhttps://modernod.com/news/clearside-biomedicals-partner-doses-first-patient-in-its-phase-2-study-in-patients-with-choroidal-melanoma-using-scs-microinjector/2478269/Clearside Biomedical announced that its licensing partner, Aura Biosciences, has dosed the first patient in its phase 2 clinical trial evaluating the safety and efficacy of suprachoroidal administration of AU-011 as a potential first-line treatment for patients with primary choroi
- AGTC Announces Publication of Preclinical Data that Support the Ongoing Clinical Development of Its XLRP Gene Therapy Programhttps://modernod.com/news/agtc-announces-publication-of-preclinical-data-that-support-the-ongoing-clinical-development-of-its-xlrp-gene-therapy-program/2478200/Applied Genetic Technologies Corporation (AGTC) announced that preclinical data validating the transgene (hRPGRco) that is being evaluated in the company’s ongoing phase 1/2 clinical trial in patients with X-lined retinitis pigmentosa (XLRP) have been published in the July 15, 2020 print issue of
- BVI Partners With HVO to Provide PPE for Healthcare Workershttps://modernod.com/news/bvi-partners-with-hvo-to-provide-ppe-for-healthcare-workers/2478155/BVI has partnered with Haywood Vocational Opportunities (HVO) to provide isolation gowns to US healthcare workers on the front lines of the pandemic effort. HVO is a US based medical product manufacturer who provides vocational training and employment opportunities for adults with disadva
- Topcon Acquires Henson Perimeter Businesshttps://modernod.com/news/topcon-acquires-henson-perimeter-business/2478033/Topcon Healthcare announced that it has acquired the Henson line of perimetry products, including the Henson 9000 and 7000, from Elektron Eye Technology (EET) of Cambridge, UK. Terms of the deal were not disclosed. The acquisitions include the transfer of a number of EET staff to To
- New Visionix VX65 Digital Phoropter Helps ECPs Meet Social Distancing Recommendationshttps://modernod.com/news/new-visionix-vx65-digital-phoropter-helps-ecps-meet-social-distancing-recommendations/2477756/Luneau Technology USA announced the expansion of its Visionix product line with the addition of the Visionix VX65 digital phoropter. With the majority of refractions are still being conducted with a manual phoropter, the VX65 provides a smooth transition for eye care professionals looking to init
- FDA Increases Oversight, Requirements for COVID-19 Antibody Testshttps://modernod.com/news/fda-increases-oversight-requirements-for-covid-19-antibody-tests/2477723/After allowing unreviewed antibody tests to pervade the U.S. market for weeks, the FDA is closing its open-door policy for coronavirus blood serology tests—bringing their oversight more in line with the molecular diagnostics used to confirm active cases of COVID-19, according to a Fierc
- CMS Announces Relief for Clinicians, Providers, Hospitals and Facilities Participating in Quality Reporting Programs in Response to COVID-19https://modernod.com/news/cms-announces-relief-for-clinicians-providers-hospitals-and-facilities-participating-in-quality-reporting-programs-in-response-to-covid-19/2477433/On Sunday, The Centers for Medicare & Medicaid Services (CMS) announced relief for the clinicians, providers, and facilities participating in Medicare quality reporting programs, including the 1.2 million clinicians in the Quality Payment Program and on the front lines of America’s fight agai
- Aura Biosciences Announces Updated Phase 1b/2 Clinical Data for AU-011 Presented at AAOhttps://modernod.com/news/aura-biosciences-announces-updated-phase-1b-2-clinical-data-for-au-011-presented-at-aao/2477015/Aura Biosciences announced the presentation of updated clinical data from its ongoing phase 1b/2 clinical trial evaluating the safety and efficacy of light-activated AU-011, the company’s lead product candidate for the first line treatment of primary choroidal melanoma, at the American Academy of
- Zeiss and Senorics Establish Partnership Focus on Joint Development of Sensor Technologyhttps://modernod.com/news/zeiss-and-senorics-establish-partnership-focus-on-joint-development-of-sensor-technology/2476952/Zeiss announced that it has invested in Dresden, Germany-based Senorics. The partnership aims to further the joint development of small and cost-effective sensors for industrial use in quality assurance and in process monitoring, e.g. on production lines for foodstuffs, agricultural products, pla